---

Novel drug delivery system and characterization in advance techniques

Full Text PDF Share on Facebook Share on Twitter

---

Review Article

Author Details : Sandhiya .V*, A Deepika, P Sona Jain, B Swetha, P Theresa Evangilin

Volume : 8, Issue : 1, Year : 2023

Article Page : 36-41

https://doi.org/10.18231/j.ijcaap.2023.006

Suggest article by email

Get Permission

Abstract

Inflammatory diseases, cancer, cardiovascular diseases, Alzheimer's disease, atherosclerosis, and other degenerative diseases are all primarily brought on by oxidative damage disorders, also known as oxidative stress. This article seeks to provide an overview of the therapeutic potential of Gallic acid as a nanocarrier for disorders caused by oxidative damage. Gallic acid has also been found to have anti-inflammatory, antiviral, antibacterial, and significant antioxidant properties. Because of its slow absorption and low bioavailability, the usage of Gallic acid is constrained. The use of nanoformulation can help to remedy this. Nanotechnology has made it possible to deliver medications to the target site quickly and effectively. The medicinal efficacy of naturally occurring potential natural plant compounds has been hampered by poor water solubility and bioavailability.Nanocarriers have been used in recent studies to try to diagnose these issues because they are a logical method. They are created for controlled release at the target place in addition to safeguarding the medication from the internal environment and degradation after administration. Nanotechnology can be employed as a promising new method of medicine delivery to decrease the negative effects of natural substances.
 

Keywords: Gallic acid, Oxidative stress, Nanomedicine, Antioxidant activity, Anti­inflammatory activity, Novel drug delivery system

How to cite : Sandhiya .v, Deepika A, Jain P S, Swetha B, Evangilin P T, Novel drug delivery system and characterization in advance techniques. IP Int J Compr Adv Pharmacol 2023;8(1):36-41

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.